Cargando…
Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway
Our previous research showed that Gankyrin was overexpressed in NSCLC and significantly associated with clinicopathologic features and poor prognosis. In this study, we will explore potential effect of Gankyrin on EMT and metastasis in NSCLC. The ectopic higher expression of Gankyrin markedly increa...
Autores principales: | Wang, Wu-ping, Sun, Ying, Lu, Qiang, Zhao, Jin-bo, Wang, Xue-jiao, Chen, Zhao, Ni, Yun-feng, Wang, Ju-zheng, Han, Yong, Zhang, Zhi-pei, Yan, Xiao-long, Li, Xiao-fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351600/ https://www.ncbi.nlm.nih.gov/pubmed/27992365 http://dx.doi.org/10.18632/oncotarget.13947 |
Ejemplares similares
-
Gankyrin gene deletion followed by proteomic analysis: insight into the roles of Gankyrin in Tumorigenesis and Metastasis
por: Luo, Xue, et al.
Publicado: (2012) -
Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma
por: Sakurai, Toshiharu, et al.
Publicado: (2017) -
The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3
por: Sakurai, Toshiharu, et al.
Publicado: (2017) -
STAT3 selectively interacts with Smad3 to antagonize TGF-β signaling
por: Wang, Gaohang, et al.
Publicado: (2015) -
LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/stat3/akt pathway
por: Song, Xuan, et al.
Publicado: (2013)